|Systematic (IUPAC) name|
|Legal status||Schedule I (US)|
|Mol. mass||325.40 g/mol|
|(what is this?)|
N-methyl-3-piperidyl benzilate is less potent and shorter acting than 3-quinuclidyl benzilate, but like 3-QNB its effects on the central nervous system predominate over peripheral effects. It produces deliriant and hallucinogenic effects similar to those of plants such as datura and may be used recreationally at low doses, however unpleasant side effects such as dysphoria, nausea and vomiting, dizziness and extreme dry mouth tend to make abuse of drugs of this kind uncommon. Both the N-methyl and N-ethyl analogues of 3-piperidyl benzilate are however Schedule I controlled drugs.
- Takahashi, K.; Murakami, M.; Miura, S.; Iida, H.; Kanno, I.; Uemura, K. (1999). "Synthesis and autoradiographic localization of muscarinic cholinergic antagonist (+)N-[11C]methyl-3-piperidyl benzilate as a potent radioligand for positron emission tomography". Applied Radiation and Isotopes 50 (3): 521–525. doi:10.1016/S0969-8043(97)10155-5. PMID 10070712.
|This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it.|